Tori L. Fournier, BSc

Evidence-based guidelines support the safe and effective administration of Ig therapy in clinical practice.

Many patients do not attain sufficient disease control with inhaled corticosteroids in combination with long-acting β-2 agonists and remain vulnerable to exacerbations.

Adherence to thiopurine medications after 6 months of use was 87.9% under direct pharmacist care but 65.7% under general practitioner guidance.